share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4：持股變動聲明-董事 Borgeson Blake
美股SEC公告 ·  09/20 05:50

牛牛AI助理已提取核心訊息

Blake Borgeson, a key figure at Recursion Pharmaceuticals, completed a sale of 11,447 shares of the company's Class A Common Stock on September 17, 2024. The transaction was carried out on the open market at a price of $6.8431 per share, resulting in a total sale value of approximately $78,332.97. Following the sale, Borgeson's direct holdings in Recursion Pharmaceuticals amount to 7,109,875 shares. This sale reflects a transaction in the company's stock and may be of interest to current or potential investors.
Blake Borgeson, a key figure at Recursion Pharmaceuticals, completed a sale of 11,447 shares of the company's Class A Common Stock on September 17, 2024. The transaction was carried out on the open market at a price of $6.8431 per share, resulting in a total sale value of approximately $78,332.97. Following the sale, Borgeson's direct holdings in Recursion Pharmaceuticals amount to 7,109,875 shares. This sale reflects a transaction in the company's stock and may be of interest to current or potential investors.
Recursion Pharmaceuticals的關鍵人物Blake Borgeson於2024年9月17日完成了對該公司A類普通股的11,447股的出售。該交易在開放市場上以每股6.8431美元的價格完成，總銷售價值約爲78,332.97美元。在此次出售後，Borgeson在Recursion Pharmaceuticals的直接持股數爲7,109,875股。此次出售反映了該公司股票的交易情況，可能對現有或潛在的投資者具有一定的意義。
Recursion Pharmaceuticals的關鍵人物Blake Borgeson於2024年9月17日完成了對該公司A類普通股的11,447股的出售。該交易在開放市場上以每股6.8431美元的價格完成，總銷售價值約爲78,332.97美元。在此次出售後，Borgeson在Recursion Pharmaceuticals的直接持股數爲7,109,875股。此次出售反映了該公司股票的交易情況，可能對現有或潛在的投資者具有一定的意義。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間